Elevated COX‐2 levels boost PGE2 synthesis and release by TAN in the TME, leading to the upregulation of indoleamine 2,3‐dioxygenase 1 (IDO‐1) in urothelial bladder cancer cells [113]. This evidence concerns the gene IDO1 and bladder transitional cell carcinoma.